Company Filing History:
1 out of 44 
1 out of 17 
1 out of 2 Years Active: 2013-2021
Title: Volker Lennerz: Innovating in Tumor Immunology
Introduction
Volker Lennerz, based in Ober-Olm, Germany, is a distinguished inventor known for his significant contributions to the field of tumor immunology. With a commendable portfolio of three patents, Lennerz is dedicated to advancing medical treatments and diagnostics for tumor diseases. His latest innovations focus on the development of MHC-independent tumor-associated antigens, which play a crucial role in eliciting CD8-positive T-cell responses.
Latest Patents
Lennerz’s recent patents revolve around two main inventions that target novel tumor-associated antigens. The first invention emphasizes the importance of MHC-independent responses, highlighting GM-CSF-receptor alpha chain (CSF2RA) and Tyrosinase-related protein 2 (TRP-2) as pivotal targets for CD8-positive T-cell clones. These innovations present proteins, protein fragments, and polypeptides of the newly identified antigens for medical use, specifically aimed at the treatment, diagnosis, and prevention of tumor diseases. Additionally, his inventions encompass nucleic acids that express these antigens, as well as specific binding agents like T-cell receptor chains and isolated T cells that are reactive against the identified antigens. The patent further details pharmaceutical compositions, particularly vaccine formulations, that incorporate these advancements.
Career Highlights
Volker Lennerz has made notable strides in his career, including significant roles at reputable institutions. He has worked at Johannes Gutenberg University Mainz, where he contributed to groundbreaking research and education. Furthermore, he was affiliated with BioNTech RNA Pharmaceuticals GmbH, a company recognized for its innovative approaches in mRNA technology and cancer immunotherapy. These career highlights showcase his commitment to enhancing the field of biotechnology and medical sciences.
Collaborations
Throughout his career, Lennerz has collaborated with esteemed colleagues, including Martina Fatho and Dirk Schadendorf. These partnerships have undoubtedly fostered a conducive environment for innovation, allowing for the exchange of ideas and expertise that are crucial in the domain of tumor immunology.
Conclusion
In summary, Volker Lennerz is an influential inventor in the medical field, specializing in the development of MHC-independent tumor-associated antigens. His innovative patents provide significant insights and potential solutions for tumor disease treatment and prevention. With a strong career foundation and meaningful collaborations, Lennerz continues to pave the way for groundbreaking advancements in immunotherapy and cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.